AHR and asthma: CXCR4 is also involved in Th2 cell migration into the lungs [58] and treatment of allergic mice with selective CXCR4 inhibitors significantly reduces AHR and inflammatory responses [59,60], supporting the further development of CXCR4 antagonists for asthma treatment.